Turning hope into help

It all starts with the patient. With the need to ease the anxieties associated with critical moments in their lives. All over the world, from big cities to small towns, there are patients, families, and loved ones all hoping for treatments and cures.

Huge advances in technologies, like genomics, have catalyzed incredible advances in the biopharmaceutical industry. Today it’s possible not just to treat the symptoms of rare diseases but to treat the causes too. Cures, which as recently as a decade ago were thought impossible, have become a reality.

While the capacity to handle millions of samples at a time is critical for clinical trial laboratories, the key to success is the ability to find the solution to the exceptions, the rare cases. To handle these exceptions takes a rare company. It takes Q² Solutions. Our competitive edge isn’t just through our industry-leading science, our partnership approach, or in our innovative solutions; it’s found in the unique combination of all three. Like a complex molecule, we solve problems that couldn’t have been attempted before.

With the support of our strategic partners and customers, who comprise the world’s largest biopharmaceutical companies as well as hundreds of others, we continue to push the boundaries of science and innovation in the clinical trial laboratory space. Though the size, cost, and complexity of trials may vary, our commitment to our partners does not. Whatever your needs, however complex the problem, we stand ready to partner with you to develop the solution. Our experience in supporting complex trials with cutting-edge laboratory solutions is exceptional, but most importantly, we are motivated by the work that needs to done – because it’s not just a clinical trial, it’s someone’s life.

A life depends on every sample we come in contact with. There are patients out there hoping for a cure. Together, we turn that hope into help.